The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription
about
Nrf2 and Nrf1 signaling and ER stress crosstalk: implication for proteasomal degradation and autophagyRole of Nrf1 in antioxidant response element-mediated gene expression and beyondThe C-terminal domain of Nrf1 negatively regulates the full-length CNC-bZIP factor and its shorter isoform LCR-F1/Nrf1β; both are also inhibited by the small dominant-negative Nrf1γ/δ isoforms that down-regulate ARE-battery gene expressionTranscription factor Nrf1 negatively regulates the cystine/glutamate transporter and lipid-metabolizing enzymesThe Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysisCNC-bZIP protein Nrf1-dependent regulation of glucose-stimulated insulin secretionThe Nrf1 CNC-bZIP protein is regulated by the proteasome and activated by hypoxiaDeficiency in the nuclear-related factor erythroid 2 transcription factor (Nrf1) leads to genetic instabilityGlycogen synthase kinase 3 regulates expression of nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) and inhibits pro-survival function of Nrf1Long isoforms of NRF1 contribute to arsenic-induced antioxidant response in human keratinocytesStress-activated cap'n'collar transcription factors in aging and human diseaseRegulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disordersCytoprotection "gone astray": Nrf2 and its role in cancerCharacterization of Nrf1b, a novel isoform of the nuclear factor-erythroid-2 related transcription factor-1 that activates antioxidant response element-regulated genesGenetic variation and antioxidant response gene expression in the bronchial airway epithelium of smokers at risk for lung cancer.Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesityTissue-restricted expression of Nrf2 and its target genes in zebrafish with gene-specific variations in the induction profiles.Endoplasmic reticulum association and N-linked glycosylation of the human Nrf3 transcription factor.UGT genomic diversity: beyond gene duplication.p62/Sequestosome-1, Autophagy-related Gene 8, and Autophagy in Drosophila Are Regulated by Nuclear Factor Erythroid 2-related Factor 2 (NRF2), Independent of Transcription Factor TFEB.The selective post-translational processing of transcription factor Nrf1 yields distinct isoforms that dictate its ability to differentially regulate gene expressionTALENs-directed knockout of the full-length transcription factor Nrf1α that represses malignant behaviour of human hepatocellular carcinoma (HepG2) cellsThe membrane-topogenic vectorial behaviour of Nrf1 controls its post-translational modification and transactivation activity.Heterodimerization with small Maf proteins enhances nuclear retention of Nrf2 via masking the NESzip motifThe generation, detection, and effects of reactive drug metabolites.The nrf1 and nrf2 balance in oxidative stress regulation and androgen signaling in prostate cancer cells.Nrf1 and Nrf2 transcription factors regulate androgen receptor transactivation in prostate cancer cellsCompetition of nuclear factor-erythroid 2 factors related transcription factor isoforms, Nrf1 and Nrf2, in antioxidant enzyme induction.Complexity of Compensatory Effects in Nrf1 Knockdown: Linking Undeveloped Anxiety-Like Behavior to Prevented Mitochondrial Dysfunction and Oxidative Stress.HSP90 inhibitor 17-DMAG exerts anticancer effects against gastric cancer cells principally by altering oxidant-antioxidant balance.Thioredoxin system-mediated regulation of mutant Kras associated pancreatic neoplasia and cancer.Kelch-like ECH-associated protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2-related factors 1 and 2 (NRF1 and NRF2).Heme-mediated inhibition of Bach1 regulates the liver specificity and transience of the Nrf2-dependent induction of zebrafish heme oxygenase 1.H2O2 preconditioning modulates phase II enzymes through p38 MAPK and PI3K/Akt activation.
P2860
Q24296827-3BEDA782-2A3B-44D0-8420-8F69BDD636F9Q24629339-A78F9E28-9477-4C95-9D4F-4BEABC7300BAQ27341433-1389B462-C6D0-4035-A8AF-5AC6D8D05633Q28245245-015A0FF2-8020-4950-A818-BC3DF20B6F02Q28249259-BC54594C-5C80-4986-BD04-BF20EF959649Q28254868-8DA470F0-9525-44D7-8DAB-3B15D20E6D11Q28256645-B0CC5C0A-FEF7-4BC3-A1C5-2BD433F745BAQ28274930-AD48FCE3-81B4-4FB5-B15E-7CCCF68BF1C9Q28289761-6C6D012A-DE4E-4492-BB79-C5EF2548963FQ28292085-AAF91136-D3D8-4F5B-9069-84A2C875CE1FQ28384783-E8ABC1FA-0697-4DC3-B16F-25DD07BAA8CFQ28386313-42744EAC-3B34-4AD2-AA7C-82636C17C405Q28393784-B52856DD-0BE4-4F0A-A800-7781BB87C793Q28587680-08AAF89B-2AC1-4018-A786-378A99CDF270Q33651055-3F886520-22D1-4D7B-8E61-F827B28C7514Q33726669-61C05D36-C037-4152-9368-73FBB3322319Q34064777-D0F3DB93-76AC-4457-896C-E0852FADF69CQ34708452-649CF81B-B7E7-405B-8800-D34107AB2623Q35009521-A3B157F8-5D86-4B3D-8E47-DE6EBB322381Q35721701-A6895689-E032-4AD2-B000-7164CA3706AFQ35947852-EDA24834-622A-4106-A646-1D3468E86670Q35985845-005F2B1A-BD99-48BC-A4DD-440C277F9A86Q36935239-9C4ACFCD-6123-4B00-9075-FC0FD49FC919Q36944428-C1C7B3F8-8332-4176-8237-FCCB04F13C64Q38054629-5F527DE6-19C7-4FEB-90EC-C5AF4B2D401EQ38166575-681F3CB3-4F4C-45CE-BF8C-F5FCD7C5AECCQ38309430-4E6568DC-C5FF-4A69-8483-62316B62B6A8Q39097286-7E66E99B-41D5-4EEB-9478-F12BC5D9E8D0Q40706214-D7DD90FE-701B-40E5-A7C4-0A6CF9031762Q41346196-B26213EA-7243-4420-8458-AE2B752277E3Q46149679-B6A83B24-C0C0-412C-AFDD-3CDD8028BE1FQ47279133-CC1D6905-43EE-4F8C-9428-F1960ACA5962Q50586560-6B5F302B-7CB3-44C1-A529-8A433E1E8DB2Q54597763-BDAADC74-8262-4F61-9CAC-E5D60F3DE674
P2860
The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription
@ast
The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription
@en
The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription
@nl
type
label
The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription
@ast
The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription
@en
The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription
@nl
prefLabel
The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription
@ast
The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription
@en
The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription
@nl
P2093
P2860
P3181
P356
P1476
The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription
@en
P2093
Annie M Kwok
Jefferson Y Chan
Weiping Wang
P2860
P304
P3181
P356
10.1074/JBC.M700159200
P407
P577
2007-08-24T00:00:00Z